arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PFIZER INC

PFE
$28.43 ▲ +0.28 (+0.99%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

PFIZER INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $161.6B
Dividend Yield 6.05%
Revenue Growth -1.6% ↘
Op. Margin —
ROIC —
FCF / Share $1.60 ↘
Trailing P/E 20.8x
Price / Book 1.9x
FCF Yield 5.6%
Debt / Equity 0.71
info Valuation on last close. End-of-day price, Sep 24, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$62.58B
↓ -1.6% —
Net Income Profit after all expenses
$7.77B
↓ -3.2% —
FCF / Share Free cash flow per share
$1.60
↓ -8.0% —
Long-Term Debt Long-term obligations
$61.64B
↑ +7.4% —

Health Breakdown

Profitability ↓
70
Returns ↓
64
Financial Health ↑
39
Cash Quality ↓
72

Dividend History

Dividend / share · sourced from SEC filings
$1.72 Latest / share
+1.8% YoY
+4.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 20 years · 75 quarters